Toxic effect of tumor necrosis factor on tumor vasculature in mice
- PMID: 3349488
Toxic effect of tumor necrosis factor on tumor vasculature in mice
Abstract
Stereoscopic observation via an implanted sight glass in mice bearing transplanted methylcholanthrene-induced A-cells showed tumorivascular hemorrhage at 1-2 h after tumor necrosis factor (TNF) administration, congestion at 4-6 h, and hemorrhage, congestion, and blood circulation blockage at 24 h. Histological examination after TNF administration to mice bearing similar methylcholanthrene-induced A-cell transplants showed thrombus formation in the tumor vasculature at 4 h and thereafter. Suppression of this thrombus formation with heparin had no apparent influence on the necrotic response, tumor growth inhibition or complete cure rate following TNF administration to mice bearing the methylcholanthrene-induced A-cell tumors. The results suggest that direct toxicity of TNF on tumor vasculature is a factor in the overall antitumor mechanism of TNF.
Similar articles
-
[The mechanism of action of tumor necrosis factor (TNF) on tumor vascularity--study using a transparent chamber].Gan To Kagaku Ryoho. 1987 Dec;14(12):3337-43. Gan To Kagaku Ryoho. 1987. PMID: 3318706 Japanese.
-
Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.Cancer Res. 2003 Nov 15;63(22):7584-90. Cancer Res. 2003. PMID: 14633671
-
Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.Cancer Res. 1986 Nov;46(11):5687-90. Cancer Res. 1986. PMID: 3756916
-
Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.Ciba Found Symp. 1987;131:185-91. Ciba Found Symp. 1987. PMID: 3330010 Review. No abstract available.
-
[Tumor necrosis factor (TNF)].Rinsho Byori. 1989 Jul;(Spec No 82):17-28. Rinsho Byori. 1989. PMID: 2693766 Review. Japanese. No abstract available.
Cited by
-
Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.Immunol Res. 2014 Jan;58(1):87-100. doi: 10.1007/s12026-013-8434-7. Immunol Res. 2014. PMID: 24072428 Review.
-
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.Ann Surg. 1996 Dec;224(6):756-64; discussion 764-5. doi: 10.1097/00000658-199612000-00011. Ann Surg. 1996. PMID: 8968230 Free PMC article. Clinical Trial.
-
Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action.Neoplasia. 2010 Sep;12(9):755-65. doi: 10.1593/neo.10636. Neoplasia. 2010. PMID: 20824052 Free PMC article.
-
CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans.Magn Reson Med. 2019 Oct;82(4):1471-1479. doi: 10.1002/mrm.27818. Epub 2019 May 20. Magn Reson Med. 2019. PMID: 31106918 Free PMC article.
-
The diverse roles of the TNF axis in cancer progression and metastasis.Trends Cancer Res. 2016 Jan 1;11(1):1-27. Trends Cancer Res. 2016. PMID: 27928197 Free PMC article.